As part of a comprehensive approach to patient care, Yale ILD offers clinical drug trials for patients with IPF and other forms of pulmonary fibrosis. I am the primary investigator at Yale for these studies. I participate in the Center’s translational research program which is aimed at understanding the mechanisms of pulmonary fibrosis development and progression.
Supportive care for patients with pulmonary complications of connective tissue disease.
Semin Respir Crit Care Med. 2014 Apr;35(2):274-82. doi: 10.1055/s-0034-1371538. Epub 2014 Mar 25.
Pulmonary complications of connective tissue disease.
Semin Respir Crit Care Med. 2014 Apr;35(2):157. doi: 10.1055/s-0034-1371696. Epub 2014 Mar 25.
Interstitial lung disease in the connective tissue diseases.
Clin Chest Med. 2012 Mar;33(1):123-49. doi: 10.1016/j.ccm.2012.01.004.
Pulmonary manifestations of rheumatoid arthritis.
Clin Chest Med. 2010 Sep;31(3):451-78. doi: 10.1016/j.ccm.2010.04.003.
Circulating monocytes from systemic sclerosis patients with interstitial lung disease show an enhanced profibrotic phenotype.
Lab Invest. 2010 Jun;90(6):812-23. doi: 10.1038/labinvest.2010.73. Epub 2010 Apr 19.
Prognostic implications of cell cycle, apoptosis, and angiogenesis biomarkers in non-small cell lung cancer: a review.
Clin Cancer Res. 2005 Jun 1;11(11):3974-86.
Laryngeal findings in users of combination corticosteroid and bronchodilator therapy.
Laryngoscope. 2004 Sep;114(9):1566-9.
Germline mutations in BRCA1 and BRCA2 in breast-ovarian families from a breast cancer risk evaluation clinic.
J Clin Oncol. 2001 Apr 15;19(8):2247-53.
Screening for genomic rearrangements in families with breast and ovarian cancer identifies BRCA1 mutations previously missed by conformation-sensitive gel electrophoresis or sequencing.
Am J Hum Genet. 2000 Oct;67(4):841-50. Epub 2000 Sep 7.
I1307K APC variant in non-Ashkenazi Jewish women affected with breast cancer.
Am J Med Genet. 1999 Jul 16;85(2):189-90.
The APCI1307K allele and breast cancer risk.
Nat Genet. 1998 Sep;20(1):13-4.